AlteplaseA Review of Its Use in the Management of Acute Ischaemic Stroke

被引:0
作者
Sohita Dhillon
机构
[1] Adis,
来源
CNS Drugs | 2012年 / 26卷
关键词
Acute Ischaemic Stroke; Alteplase; Stroke Onset; Treatment Window; NIHSS Score;
D O I
暂无
中图分类号
学科分类号
摘要
Alteplase (Actilyse®, Activase®) is a recombinant tissue-type plasminogen activator that activates plasminogen directly to plasmin. It is the only pharmacological treatment currently approved for patients with acute ischaemic stroke. This article reviews the efficacy and tolerability of alteplase, focusing on data relevant to treatment between 0 and 4.5 hours after onset of stroke, and summarizes its pharmacological properties.
引用
收藏
页码:899 / 926
页数:27
相关论文
共 190 条
  • [1] Baldwin K.(2010)Acute ischemic stroke update Pharmacotherapy 30 493-514
  • [2] Orr S.(2007)Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups [published errata appear in Stroke. 2007 Jun; 38 (6): e38 and Stroke. 2007 Sep; 38 (9): e96] Stroke 38 1655-711
  • [3] Briand M.(2008)Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 Cerebrovasc Dis 25 457-507
  • [4] Adams H.P.(2009)Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association [published erratum appears in Stroke. 2010 Sep; 41 (9): e562] Stroke 40 2945-8
  • [5] del Zoppo G.(2009)Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic Trends Neurosci 32 48-55
  • [6] Alberts M.J.(2004)Equivocal roles of tissue-type plasminogen activator in stroke-induced injury Trends Neurosci 27 155-60
  • [7] del Zoppo G.J.(1982)Kinetics of the activation of plasminogen by human tissue plasminogen activator: role of fibrin J Biol Chem 257 2912-9
  • [8] Saver J.L.(1987)Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy J Cell Biochem 33 77-86
  • [9] Jauch E.C.(1987)On behalf of the TIMI investigators. Thrombolysis In Myocardial Infarction (TIMI): comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator J Am Coll Cardiol 10 479-90
  • [10] Yepes M.(1987)A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction J Am Coll Cardiol 9 1205-13